CMPXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Compass Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.83−0.03 (-2.91%)
Close on Oct 19, 2026
- Market cap
- $155.98M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Compass Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 22, 2026 | Sep 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2026 | Jul 1, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 22, 2026 | Jun 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2026 | Jun 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2026 | Apr 29, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 27, 2026 | Apr 27, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 5, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2026 | Mar 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2026 | Jan 6, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2025 | Jun 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2025 | Apr 1, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2025 | Jan 8, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2024 | Dec 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2024 | Jun 17, 2024 | SEC EDGAR |
| Current report | 8-K | May 28, 2024 | May 28, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 13, 2024 | SEC EDGAR |
| Current report | 8-K | May 13, 2024 | May 13, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 13, 2024 | Apr 29, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 25, 2024 | Apr 25, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 21, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2024 | Mar 21, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2024 | Jan 9, 2024 | SEC EDGAR |